2010
Requests for reprints can be addressed to:
Amorij JP, Hinrichs WLJ, Frijlink HW, Wilschut J, Huckriede A
Approaches for needle-free administration of influenza vaccines
Lancet Infectious Diseases, 10, 699-711, 2010
Elfahmi, Wirasutisna KR, Batterman S, Koulman A, Kayser O, Woerdenbag HJ, Quax WJ
Reduced coniferin and enhanced 6-methoxypodophyllotoxin production in linum flavum cell cultures
Pharmacognosy Journal, 2, 74-80, 2010
Geeraedts F, Saluja V, ter Veer W, Amorij JP, Frijlink HW, Wilschut J, Hinrichs WLJ, Huckriede A
Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures
Aaps J, 12, 215-222, 2010
de Graaf A, Olinga P, de Jager MH, Merema MT, de Kanter R, van de Kerkhof EG, Groothuis GM
Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.
Nat Protoc, 5, 1540-1551, 2010
Hendrawati O, Woerdenbag HJ, Hille J, Kayser O
Metabolic engineering strategies for the optimization of medicinal and aromatic plants: realities and expectations
Zeitschrift für Arznei- & Gewürzpflanzen, 15, 111 -126, 2010
Laksmana FL, Hartman Kok PJ, Frijlink HW, Vromans H, Van der Voort Maarschalk K
Gas permeation related to the moisture sorption in films of glassy hydrophilic polymers
J Appl Polym Sci, 116, 3310-3317, 2010
Nguyen TT, Rambanapasi C, de Boer AH, Frijlink HW, van der Ven PM, de Vries J, Busscher HJ, Van der Voort Maarschalk K
A centrifuge method to measure particle cohesion forces to substrate surfaces: The use of a force distribution concept for data interpretation
Rottier BL, de Boer AH, Duiverman EJ
Inhaled medication and inhalation devices for lung disease in patients with Cystic Fibrosis. A European consensus: additional questions and answers. Which area to target? Which particle size to deliver? Which device to use?
J Cystic Fibrosis, 9, 296-297, 2010
Saluja V, Amorij JP, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WLJ, Frijlink, HW
Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant
Saluja V, Amorij JP, Kapteyn JC, de Boer AH, Frijlink HW, Hinrichs WLJ
A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation
J Control Release, 144, 127-133, 2010
Saluja V, Hinrichs WLJ, Frijlink HW
Dried influenza vaccines: Over the counter vaccines
Human Vaccines, 6, 854-856, 2010
Saluja V, Visser MR, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WLJ, Frijlink HW
Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with
Gram-positive enhancer matrix (GEM) particles
Eur J Pharm Biopharm, 76, 470-474, 2010
Saluja V, Visser MR, ter Veer W, van Roosmalen ML, Leenhouts K, Hinrichs WLJ, Huckriede A, Frijlink HW
Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
Schaffert CS, Duryee MJ, Bennett RG, DeVeney AL, Tuma DJ, Olinga P, Easterling KC, Thiele GM, Klassen LW
Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis
Am J Physiol Gastrointest Liver Physiol, 299, G661-668, 2010
Schellekens RCA, Olsder G, Maurer M, Kosterink J, Woerdenbag HJ, Wutzke KD, Frijlink HW, Stellaard F
C-13-urea and N-15(2)-urea: elegant markers to define location and kinetics of in vivo release from a colon-targeted delivery device in men
Eur J Clin Invest, 40, Suppl. 1, 66, 2010
Schellekens RCA, Stellaard F, Olsder GG, Woerdenbag, HJ, Frijlink HW, Kosterink JG
Oral ileocolonic drug delivery by the colopulse-system: A bioavailability study in healthy volunteers
J Control Release, 146, 334-340, 2010
Srinarong P, Kouwen S, Visser MR, Hinrichs WLJ, Frijlink HW
Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets
Pharm Dev Technol, 15, 460-468, 2010
Staniek A, Muntendam R, Woerdenbag HJ, Kayser O
The essential oil constituents derived from different organs of a relictual conifer Wollemia nobilis
Biochemical Systematics and Ecology, 38, 131-135, 2010
Staniek A, Woerdenbag HJ, Kayser O
Screening the endophytic flora of Wollemia nobilis for alternative paclitaxel sources
Journal of Plant Interactions, 5, 189-195, 2010
van der Steen KC, Frijlink HW, Schipper MA, Barends DM
Prediction of the ease of subdivision of scored tablets from their physical parameters
AAPS PharmSciTech, 11, 126-132, 2010
Tu H-AT, Bos JHJ, Woerdenbag HJ, Visser ST, Wilschut JC, Van Assen S, De Jong-van den Berg LTW, Postma MJ
Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the Northern Netherlands between 2000 and 2006
Clinical Therapeutics, 32,133-144, 2010
Tu HAT, de Vries R, Woerdenbag HJ, van Hulst M, Postma MJ
Cost-effectiveness of universal hepatitis B immunization in Vietnam: Application of cost-effectiveness affordability curves in health decision-making
Value in Health, 13, A250, 2010
Tu HAT , Riewpaiboon A, Woerdenbag HJ, Postma MJ, Li SC
Cost-of-illness of chronic hepatitis B infection in Vietnam
Value in Health, 13, A548, 2010
Visser MR, Baert L, Klooster GV, Schueller L, Geldof M, Vanwelkenhuysen I, de Kock H, De Meyer S, Frijlink HW, Rosier J, Hinrichs WLJ
Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240
Eur J Pharm Biopharm, 74, 233-238, 2010
de Waard H, Amani A, Kendrick J, Hinrichs WLJ, Frijlink HW, Anwar J
Evaluation and optimization of a force field for crystalline forms of mannitol and sorbitol
J Phys Chem B, 114, 429-436, 2010
de Waard H, De Beer T, Hinrichs WLJ, Vervaet C, Remon JP, Frijlink HW
Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy
Willemsz TA, Oostra W, Hooijmaijers R, de Vegt O, Morad N, Vromans H, Frijlink HW, Van der Voort Maarschalk K
Blending of agglomerates into powders 1: Quantification of abrasion rate
| Laatst gewijzigd: | 10 januari 2020 09:15 |